Abstract
Antibody responses to subunit influenza vaccine prepared against A2/England/42/72 (h3n2) were studied in 69 volunteers aged 60 and over and 231 aged 59 and below over 12 months in 1973 and 1974. After two doses of vaccine seroconversion frequencies and geometric mean haemagglutination-inhibition (HI) titres were higher in the elderly, but no differences were observed between the two groups in the length of their responses. Sixteen (23%) of the elderly volunteers seroconverted only after receiving a second dose of vaccine or seroconverted twice after receiving both doses of vaccine. It was considered justifiable, therefore, to recommend the continuation of a two-dose schedule for patients in a high-risk category. Within 30 weeks of vaccination 87 (29%) volunteers had considerably reduced HI titres (less than 48), which might indicate potential susceptibility to influenza during an epidemic, and the number had risen to 132 (44%) by 50 weeks. It was suggested that high-risk patients should receive annnual vaccination two to four months before the possible epidemic period.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- EICKHOFF T. C., SHERMAN I. L., SERFLING R. E. Observations on excess mortality associated with epidemic influenza. JAMA. 1961 Jun 3;176:776–782. doi: 10.1001/jama.1961.03040220024005. [DOI] [PubMed] [Google Scholar]
- Evans A. S., Jeffrey C., Niederman J. C. The risk of acute respiratory infections in two groups of young adults in Colombia, South America. A prospective seroepidemiologic study. Am J Epidemiol. 1971 Jun;93(6):463–471. doi: 10.1093/oxfordjournals.aje.a121280. [DOI] [PubMed] [Google Scholar]
- Hobson D., Baker F. A., Curry R. L. Effect of influenza vaccines in stimulating antibody in volunteers with prior immunity. Lancet. 1973 Jul 21;2(7821):155–156. doi: 10.1016/s0140-6736(73)93106-1. [DOI] [PubMed] [Google Scholar]
- Hobson D., Curry R. L., Beare A. S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972 Dec;70(4):767–777. doi: 10.1017/s0022172400022610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Howells C. H., Evans A. D., Vesselinova-Jenkins C. Effect of two doses of influenza vaccine in stimulating antibody in volunteers. Lancet. 1973 Jun 23;1(7817):1436–1438. doi: 10.1016/s0140-6736(73)91755-8. [DOI] [PubMed] [Google Scholar]
- Mackenzie J. S., Mackenzie I., Lloyd J., Dent V. Comparative trials of live attenuated and detergent split influenza virus vaccines. J Hyg (Lond) 1975 Dec;75(3):425–443. doi: 10.1017/s0022172400024499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marine W. M., Thomas J. E. Age-related response to 1000 CCA unit zonally purified, inactivated influenza vaccines in volunteers in the U.S.A. Postgrad Med J. 1973 Mar;49(569):164–168. doi: 10.1136/pgmj.49.569.164. [DOI] [PMC free article] [PubMed] [Google Scholar]